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In-situ forming polymeric gelling systems has become prominent among novel drug delivery system (NDDS) 
in recent years due to advantages such as sustained and prolonged drug action, improved patient compliance 
and reduced frequency of administration of the drug in comparison to conventional drug delivery system 
(DDS). This is a type of mucoadhesive DDS where the polymeric formulation is in sol form before 
administration and once comes in contact with body fluids; it undergoes gelation to form a gel. The 
formulation of gel depends upon factors like temperature modulation, pH changes, presence of ions and 
ultraviolet irradiation from which drug gets released in sustained and controlled manner. Conventional 
formulation for the treatment of dental diseases has certain drawbacks. A new concept of in situ gel was 
develop to overcome the shortcoming of conventional formulation which deals with dental diseases. 
Conventional oral formulations like solution, suspension, and ointments have many disadvantages which 
result into poor bioavailability of drug in the buccal cavity. In-situ forming polymeric formulation drug 
delivery systems is in sol form before administration in the body, but once administered, undergoes gelation 
in-situ to form a gel. 
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INTRODUCTION 
Dental diseases are a major health problem in all parts 
of the world, common in all age groups, races and 
genders. The percentage of dental diseases has grown to 
a large extent in recent years. Around 70% of 
population suffers from dental problems. The human 
population is affected by major of oral diseases like 
periodontal infections, dental caries, dry socket.                  
For most of the reasons tooth extraction is unavoidable 
and hence, post extractive complications like excessive 
bleeding, delayed wound healing, dry socket syndrome 
etc. are also of great concern [1]. According to estimates 
by Government of India-World Health Organization 
collaborative programme, about 50% of school children 
are suffering from Dental caries and more than 90% of 
adults are having periodontal diseases [2]. 
In-situ is a Latin word which means „In its original 
place or in position‟ [3].  The gelation can be triggered 
by temperature, pH change, ionic change and also UV 
induced gelation, Solvent exchange induced gelation 
[4]. In situ drug delivery system offers advantages such 
as reduced frequency of administration, improved 
patient compliance, and comfort. An in situ gel 
formulation provides an interesting alternative for 
achieving effective plasma drug concentration, an 
advantage over conventional delivery systems [5]. The 
stimuli that induces various responses to form hydrogels 
includes: Physical stimuli such as change in 
temperature, electric fields, light, pressure, sound, and 
magnetic fields; chemical stimuli such as change in pH 
and ion activation from biological fluids; and biological 
or biochemical stimuli such as change in glucose level. 
Out of these different environmental conditions only 
pH, ion activated, and temperature stimuli are used for 
dental drug delivery system [6,7]. 
 
Anatomy and physiology of oral cavity: 
Oral cavity  
The oral cavity is lined with mucus membranes with a 
total surface area of 200cm2. The oral cavity has distinct 
areas: 
1) The floor of mouth (sublingual)  
2) The buccal area (Cheeks)  
3) The gums (gingival), The palatal region.(Hard palate 
and soft palate) [8]. (Figure. 1)  
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DENTAL DISEASES 
Periodontal Disease: The word “Perio" means around, 
and "dontal" refers to teeth. Teeth and their supporting 
(periodontal) structures are of main importance to oral 
health. Dental diseases are among the widest spread 
chronic disorder affecting mankind [9]. Periodontal 
disease are a group of clinical conditions which affect 
the supportive structure of the teeth and are 
characterized by infection and inflammation. The 
development of periodontotis involves periodontal 
tissue breakdown and result from an interaction between 
the affecting organisms. Conventional therapy, based on 
scaling, surgery and the use of antibiotics or 
antimicrobials has been proposed [10]. 
 
Figure 1: Anatomy of oral cavity 
These conditions are characterized by a destruction of 
the periodontal ligament, a resorbtion of the alveolar 
bone and the migration of the junctional epithelium 
along the tooth surface. The clinical signs of 
periodontitis are changes in the morphology of gingival 
tissues, bleeding upon probing as well as periodontal 
pocket formation. This pocket provides an ideal 
environment for the growth and proliferation of 
anaerobic pathogenic bacteria [11]. (Figure. 2) 
                            
Figure. 2: Healthy V/S Gum Disease 
 
Classification of Periodontal Disease: 
The American Academy of Periodontology 
classification system identifies distinct types of 
periodontal diseases, clinical appearance, rate of disease 
progression, pathogenic microbial flora and systemic 




Gingivitis is a chronic inflammatory process limited to 
the gingiva without either attachment loss or alveolar 
bone loss. It is one of the most frequent oral diseases, 
affecting more than 90% of the population, regardless of 
age, sex, or race [12]. Gingivitis can usually be treated 
simply. Gingivitis is often caused by inadequate oral 
hygiene.  Plaque and tartar are removed from teeth; the 





a) Plaque-Associated Gingivitis 
Gingival redness, edema, bleeding upon probing, 
enlargement and tenderness 
b) Chronic Gingivitis 
Inflammation of the gingival, resulting in loss of clinical 
attachment due to periodontal ligament destruction and 
loss of the adjacent supporting bone 
c) Acute Necrotizing Ulcerative Gingivitis 
Patients diagnosed with Acute Necrotizing Ulcerative 
Gingivitis may present with the following clinical 
findings: Papillary necrosis, bleeding, pain and fetor 
oris (odor). 
d) Gingivitis Associated with Systemic Conditions or 
Medications 
 Hormone-Induced Gingival Inflammation:- 
Gingival redness, bleeding upon probing, edema and 
gingival enlargement associated with proliferation of 
blood vessels. 
 Drug-Influenced Gingivitis 
Fibrotic gingival response, pseudo pockets and bleeding 
upon probing 
 Linear Gingival Erythema (LGE) 
Patients that are HIV+ may exhibit this type of gingival 
response.    
e) Gingival Manifestations of Systemic Diseases and 
Mucocutaneous Lesions 
 Bacterial, Viral or Fungal: Two examples Acute 
Herpetic Gingivostomatitis or Candida Albicans 
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 Blood Dyscrasias (for example Acute Monocytic 
Leukemia): Clinical Findings: spontaneous bleeding 
upon probing or by simply touching the gingival 
tissues. 
 Mucocutaneous Diseases (Lichen Planus, Cicatricial 
Pemphigoid): include; Lichen Planus, Pemphigus 
Vulgaris and Desquamative Gingivitis [14].     
 
2. Periodontitis 
Periodontitis is the common oral disease affecting many 
people around the world. It is defined as an 
inflammation and progressive destruction of the tooth-
supporting structures (periodontium). Periodontitis 
involves progressive loss of the alveolar bone around 
the teeth, and if left untreated, can lead to the loosening 
and subsequent loss of teeth. A diagnosis of 
Periodontitis is established by inspecting the soft gum 
tissues around the teeth with a probe (i.e. a clinical 
exam) and by evaluating the patient's x-ray films (i.e. a 
radiographic exam), to determine the amount of bone 
loss around the teeth.   This disease results from 
interaction between specific host defence mechanisms 
and dental plaque bio films that colonize on the tooth 
surfaces at or below the gingival margin [14, 15].  
Types of periodontitis:- 
a) Plaque-Associated Periodontitis:- 
The presence of local factors such as plaque is usually 
comparable with the disease progression. 
b) Early-Onset Periodontitis:- 
• Prepubertal: A rare periodontal disease, onset is often 
during or immediately following eruption of the 
deciduous dentition and rapid destruction of bone. 
• Juvenile Periodontitis: In these patients, there is rapid 
loss of attachment, bilateral symmetry is common, 
destruction of bone is often localized to first permanent 
molars, and mild to moderate inflammatory response. 
• Rapidly Progressive: This case is a young female 
diagnosed with Rapidly Progressive Periodontitis. 
c) Periodontitis Associated with Systemic Diseases: 
With certain systemic conditions the inflammatory 
response is altered in the presence of local irritants 
thereby, accelerating the progression of periodontal 
disease.  
d) Necrotizing Ulcerative Periodontitis: 
Findings may include erythema, ulceration and necrosis 
of the gingival margin, with destruction of the 
supporting bone.  
e) Refractory: 
These types of cases normally do not respond to "well-
executed" periodontal therapy. 
f) Peri-implantitis: 
This is a new category established by the AAP. Patients 
in this category have implants that exhibit a 
"periodontitis-like-process" similar to natural teeth. 
 
Method of Preparation: 
Polymerization in situ:- 
This method is used for preparation of sheets of cross-
linked polymer sheets in which drug can be 
incorporated. A liquid polymer or pre polymerized 
inside a suitable mould. The release from monolithic 
devices depends on diffusion of drug through matrix. 
By manipulating the system, selecting the ideal 
polymer, adjusting the cross-linking, fillers, plasticizers 
and by using co-polymers, release of some low 
molecular drug can be achieved. For an antimicrobial 
agent to be successful the pathogen must be known, it 
must be susceptible to the drug. It should not readily 
develop resistance for an adequate period of time. Also 
the drug should have little or no side effects[16]. 
 
EVALUATION AND CHARACTERIZATION OF 
IN SITU GELLING SYSTEM: 
1. Clarity: The clarity of formulated solutions can be 
determined by visual inspection under black and white 
background [17]. 
2. Drug content: The drug concentration is determined 
by using a UV-visible spectrophotometer at suitable 
wavelength against a suitable blank solution [18]. 
3. Gelation temperature and gel time: The sol-gel 
transition temperature may be defined as that 
temperature at which the phase transition of sol 
meniscus is first noted when kept in a sample tube at a 
specific temperature and then heated at specific rate. 
Gel formation is indicated by a lack of movement of 
meniscus on tilting the tube [19].   
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4. Fourier Transforms Infrared Spectroscopy and 
Thermal analysis:  During gelation process, the nature 
of interacting forces can be evaluated using this 
technique by employing potassium bromide (KBr) pellet 
method. Thermo-gravimetric analysis (TGA) can be 
conducted for in-situ forming polymeric system to 
calculate the percentage of water in hydro gel. 
Differential Scanning Calorimetry (DSC) is used to 
observe any change in thermograms as compared with 
pure ingredients used thus indicates the interaction [20]. 
 
5. Viscosity and Rheological studies: This is an 
important parameter for the in situ gels, to be evaluated. 
The viscosity and rheological properties of the 
polymeric formulations, either in solution or in gel 
made with artificial tissue fluid (depending upon the 
route of administrations) instead of 5% mannitol, were 
determined with Brookfield rheometer or some other 
type of viscometers such as Ostwald's viscometer. The 
viscosity of these formulations should be such that no 
difficulties are envisaged during their administration by 
the patient, especially during parenteral and ocular 
administration [21]. 
 
6. In vitro release studies: In vitro drug release 
methods are frequently used to gain information about 
the release profiles of active ingredients when 
developing formulations. The amount of active 
ingredients released over time is analysed using a 
spectrophotometer or high performance liquid 
chromatography (HPLC)[22].  
 
7. Gel Strength: This parameter can be evaluated using 
a rheometer. Depending on the mechanism of the 
gelling agent used, a specified amount of gel is prepared 
in a beaker, from the sol form. This gel containing 
beaker is raised at a certain rate, so pushing a probe 
slowly through the gel. The changes in the load on the 
probe can be measured as a function of depth of 
immersion of the probe below the gel surface [23]. 
(Figure. 3) 
 
Figure 3: Gel strength measuring device 
8. Texture analysis: The firmness, consistency & 
cohesiveness of formulation are assessed using texture 
analyzer which mainly indicates the syringability of sol 
so the formulation can be easily administered in vivo. 
Higher values of adhesiveness of gels are needed to 
maintain an intimate contact with surfaces like tissues 
[24].  
 
9. Determination of mucoadhesive Force: The 
mucoadhesive force is calculated by taking a  section of 
mucosa from the chicken cheek portion and instantly 
fixed with mucosal side out onto each glass vial using 
rubber band[25]. The vial with chicken cheek mucosa is 
connected to the balance in inverted position while first 
vial is placed on a height adjustable pan. Then the 
height of second vial is so adjusted that the mucosal 
surfaces of both vials come in intimate contact. Then 
weight was kept rising in the pan until vials get 
detached. Mucoadhesive force was the minimum weight 
required to detach two vials. The cheek mucosa was 
changed for each measurement [26]. 
experiments Detachment stress (dynes/cm2) = mg/A 
Where, m is the weight added to the balance in grams;  
g is the acceleration due to gravity taken as 980 cm/s2;  
A is the area of tissue exposed, i.e 8.14cm2.  
 
Advantages of In-Situ Gel:[27]
 
a) Prolong drug release 
b) Reduced systemic side effect 
c) Reduced number of application 
d) Ease of administration 
e) Reduced frequency of administration 
f) Better patient compliance 
 
Approaches for in situ gelling system:[28]
 
The various approaches for in situ gelling system are: 
1. Stimuli-responsive in situ gel system 
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 a. Temperature induced in situ gel systems 
 b. pH induced in situ gel systems 
2. Osmotically induced in situ gel systems (Ion 
activated systems) 
3. Chemically induced in situ gel systems 
 a. Ionic cross linking 
 b. Enzymatic cross linking 
 c. Photo-polymerization 
 
1. Stimuli-responsive in situ gel system: 
Stimuli-responsive polymers are defined as polymers 
that undergo relatively large and abrupt, physical or 
chemical changes in response to small external changes 
in the environmental conditions [29].  
 
a) Temperature induced in situ gel systems: 
Temperature is the most widely used stimulus in 
environmentally responsive polymer systems. The 
change of temperature is not only relatively easy to 
control, but also easily applicable both in-vitro and in-
vivo[30]. The use of biomaterial whose transitions from 
sol-gel is triggered by increase in temperature is an 
attractive way to approach in-situ formation. The ideal 
critical temperature range for such system is ambient 
and physiologic temperature, such that clinical 
manipulation is facilated and no external source of heat 
other than that of body is required for trigger gelation. A 
useful system should be tailorable to account for small 
differences in local temperature, such as might be 
encountered in appendages at the surface of skin or in 
the oral cavity [31]. 
 
b) pH induced in situ gel systems:  
All the pH-sensitive polymers contain pendant acidic 
or basic groups that either accept or release protons in 
response to changes in environmental pH .The polymers 
with a large number of ionizied groups are known as 
polyelectrolytes. Swelling of hydrogel increases as the 
external pH increases in the case of weakly acidic 
(anionic) groups, but decreases if polymer contains 
weakly basic (cationic) groups. The most of anionic pH-
sensitive polymers are based on PAA (Carbopol®, 
carbomer) or its derivatives [32,33]. 
 
2. Osmotically induced in situ gel systems (Ion 
activated systems): 
The polymer which shows osmotically induced gelation 
are gelrite or gellan gum, hyaluronic acid and alginates 
etc. It is assumed that the rate of gelation depend on the 
osmotic gradient across the surface of the gel. The 
aqueous polymer solution forms a clear gel in the 
presence of the mono or divalent cations typically found 
in the tear fluids. The electrolyte of the tear fluid and 
especially Na+, Ca2+ and Mg2+ cations are particularly 
suited to initiate gelation of the polymer when instilled 
as a liquid solution in the conjunctival cul-de-sac [34]. 
 
3. Chemically induced in situ gel systems: 
a. Ionic crosslinking: divalent cations, especially Ca2+. 
Likewise, alginic acid undergoes gelation in presence of 
divalent/polyvalent cations e. g. Ca2+ due to interaction 
with guluronic acid block in alginate chains [35]. 
 
b. Enzymatic crosslinking: In situ formation catalysed 
by natural enzymes has not been investigated widely but 
seems to have some advantages over chemical and 
photochemical approaches. For example, an enzymatic 
process operates efficiently under physiologic 
conditions without need for potentially harmful 
chemicals such as monomers and initiators. Intelligent 
stimuli-responsive delivery systems using hydrogels 
that can release insulin have been investigated. Cationic 
pH-sensitive polymers containing immobilized insulin 
and glucose oxidase can swell in response to blood 
glucose level releasing the entrapped insulin in a 
pulsatile fashion. Adjusting the amount of enzyme also 
provides a convenient mechanism for controlling the 
rate of gel formation, which allows the mixtures to be 
injected before gel formation [36]. 
 
Photo-polymerization: In situ photo-polymerization 
has been used in biomedical applications for over more 
than a decade. A solution of monomers or reactive 
macromer and initiator can be injected into a tissues site 
and the application of electromagnetic radiation used to 
form gel. Acrylate or similar polymerizable functional 
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groups are typically used as the polymerizable groups 
on the individual monomers and macromers because 
they rapidly undergo photo-polymerisation in the 
presence of suitable photo initiator. Photopolymerizable 
systems when introduced to the desired site via injection 
get photo cured in situ with the help of fiber optic cables 
and then release the drug for prolonged period of time. 
A photo-polymerizable, biodegradable hydrogel as a 
tissue contacting material and controlled release carrier 
is reported by Sawhney et al [37]. 
 
FUTURE PROSPECT 
• To find the other triggering factors for the in-situ gel 
formation 
• To search for the penetration enhancers devoid of side 
effects 
• To target the drug in the posterior chamber through 
non-invasive route [38] 
 
CONCLUSION 
Each drug having its own therapeutic effects can be 
administered through various routes as in-situ gels. In-
situ gel having tremendous advantages of reducing 
systemic side effect, prolong drug release, Ease of 
administration is being used widely nowadays. In-situ 
gelling systems have transformed as conventional drug 
delivery systems because of its controlled delivery and 
convenient application. In-situ gel dosage forms are 
very reliable due to sustained and prolonged drug 
release and good stability. It had been a boon in 
pharmaceutical industry to develop such a delivery 
which could be delivered at great ease. Developments 
are still on and more formulation would be formulated 
in coming times. 
 
REFERENCE 
1. Neha NM, Kishore NG. Orodental Delivery 
System. International Journal of Pharmacy and 
Pharmaceutical Sciences. 2013; 5: 1-83.   
2. Morrison HI, Ellison LF, Taylor GW et al. 
Periodontal disease and risk of fatal coronary heart 
and cerebrovascular diseases. J Cardiovasc Risk. 
1999; 6: 7-11. 
3. Ramya DD, Abhirami M, Brindha R, et al. In-situ 
Gelling System – Potential Tool for Improving 
Therapeutic Effects of  Drugs. International Journal 
of Pharmacy and Pharmaceutical Sciences. 2013; 5: 
27-29. 
4. Sarika SS, HK Kunjwani, Jayashree VK, et al. 
Novel Polymeric in Situ Gels for Ophthalmic Drug 
Delivery System. International Journal of Research 
in Pharmacy and Science. 2012; 2: 67-83.  
5. Divya K, Nidhi J, Neha G, et al. Nanoparticles 
laden in situ gelling system for oculardrug 
targeting. Journal of Advanced Pharmaceutical 
Technology & Research. 2013; 4: 9-15.  
6. Upendra N, Nidhi J, Divya K, et al. Controlled 
ocular drug delivery of ofloxacinn using 
temperature modulated in situ gelling system. 
Journal of the Scientific Society. 2013; 40: 90-94.   
7. Nanjawade BK, Manvi FV, Manjappa AS. In 
situ‑forming hydrogels for sustained ophthalmic 
drug delivery. J Control Release. 2007; 122: 
119‑34.  
8. NV Sathesh M, Ashok KS, Pragati S, et al. 
Orotransmucosal Drug Delivery System: A review. 
J Controlled Release. 2009: 2-11. 
9. Priyanka B, Yogesh SC, Suresh K, et al. An 
Overview On Treatment Of Periodontal  Disease. 
Asian Journal of Pharmacy and Medical Science. 
2013; 3: 33-34.                           
10. Shankraiah M, Nagesh C, Venkatesh JS, et al. 
Sustained Release Device Containing Ornidazole 
For Periodontitis. International Research Journal Of 
Pharmacy. 2011; 2:  217-21. 
11. Abdellaoui KS, Castioni NV, Gurny R. Local 
delivery of antimicrobial agents for the treatment of 
periodontal diseases. European Journal of 
Pharmaceutics and Biopharmaceutics. 2000: 83-93.  
12. Sakshi A, Vidya D, Bhavna JK, et al. A 
comparative evaluation of efficacy of 
Punicagranatum and chlorhexidine on plaque and 
gingivitis. Journal of the International Clinical 
Dental Research Organization. 2011; 3: 29-32. 




April – June 2014 Volume XI                                                               Issue 2  16 
 
13. Pragati S, Ashok S, Kuldeep S. Recent Advances in 
Periodpontal Drug Delivery Systems.  International 
Journal of Drug Delivery. 2009; 1: 1-14.  
14. Tapash KG, William RPF. Drug Delivery to the 
oral Cavity, Molecule to Market, Drugs and the 
Pharmaceutical sciences. Taylor and Francis group. 
New York. 2005; 145: 211-30.  
15. Pratik P, Ankur J, AK Sheth. Formulation and 
Evaluation of Sustained Release Chlorhexidine In 
Situ Gel for Periodontitis. An International Journal 
of Pharmaceutical Sciences. 2013; 4: 465-78.  
16. Varun R et al. A Brief Review on Oral Film 
Technology. International Journal of Research in 
Ayurveda and Pharmacy. 2011; 2: 1138-47.  
17. Patel PB, Shastri DH, Shelat PK, Shukla K. 
Devlopment And Evaluation Of phTrigerred In Situ 
Opthalmic In Situ Gel Formulation Of Ofloxacin. 
Am.J.Pharmatech.R. 2011;  2: 431-45. 
18. Kushal P, Piyush A, Ashok D, et al. Formulation 
and Evaluation of Oral Floatable In-situ Gel of 
Ranitidine Hydrochloride. Journal of Drug Delivery 
& Therapeutics. 2013; 3: 90-97.  
19. Kulwant S, SL Hari K. Injectable In-situ Gelling 
Controlled Release Drug Delivery System. 
International Journal of Drug Development & 
Research. 2012; 4: 56-69. 
20. Ravivarapu HB, Moyer KL, Dunn RL. Sustained 
Activity and Release of Leuprolide Acetate from an 
In-situ Forming Polymeric Implant. Pharm Sci 
Tech. 2000; 1: 216-24. 
21. Kashyap N, Viswanad B, Sharma G, et al. Design 
and evaluation of biodegradable, biosensitive in situ 
gelling systems for pulsatile delivery of insulin. 
Biomaterials. 2007; 28: 2051-60. 
22. Marie S. In Situ Gelling Drug Delivery Systems for 
Periodontal Anaesthesia. Acta Universitatis 
Upsaliensis. 2000: 1-53. 
23. Sumegha M, Surendra KJ, Nishiprakash J. 
Formulation And Evalution Of Formulation And 
Evaluation Of In Situ Ophthalmic Gel Of Ketorolac 
Tromethamine. W.J.P.P.S. 2013; 2: 1370-84. 
24. Miyazaki S, Suisha F, Kawasaki N. Thermally 
reversible xyloglucan gels as vehicles for rectal 
drug delivery. J Control Rel. 1998; 56: 75–83. 
25. Anderson BC, Pandit NK, Mallapragada SK. 
Understanding drug release from poly (ethylene 
oxide)-b-(propylene oxide)-b-poly(ethylene oxide) 
gels. J Control Release.  2001; 70: 157–67. 
26. Moore T, Croy S, Mallapragada SK, et al. 
Experimental investigation and mathematical 
modelling of Pluromic F127 gel dissolution drug 
release in stirred systems. J Control Release. 2000; 
67: 191–02. 
27. Kute JU, Darekar AB, Saudagar RB. In Situ Gel-
Noval Approach for Nasal Delivery. World Journal 
of Pharmacy and Pharmaceutical Sciences. 2013; 3: 
187-03. 
28. Aman K, Suchetha R, Shankraiah MM, et al. In 
Situ Gelling System - An Overview. 
Pharmacologyonline. 2011; 2: 28-44. 
29. Jeong B, Gutowska A. Lessons from nature: stimuli 
responsive polymers and their biomedical 
applications. Trends Biotechnol. 2002; 20: 305–11.  
30. Hoffman AS, Afrassiabi A, Dong LC. Thermally 
reversible hydrogels: II. Delivery and selective 
removal of substances from aqueous solutions.  J 
Control Release. 1986; 4: 213–22. 
31. Nirmal HB, Bakliwal SR, Pawar SP. In-situ gel: 
New trends in Controlled and Sustained Drug 
Delivery System. International Journal of Pharm 
Tech Research. 2010; 2: 1398-1408. 
32. Qiu Y, Park K. Environment-sensitive hydrogels 
for drug delivery. Adv Drug Deliv Rev. 2001; 53: 
321-39.  
33. Soppimath KS, Aminabhavi TM, Dave AM, et al. 
Stimulus-responsive “smart” hydrogels as novel 
drug delivery systems. Drug Dev Ind Pharm. 2002; 
28: 957-74. 
34. Bheskaran S, Lakshmi PK, Harish CG. Topical 
ocular drug delivery: a review. Indian Journal of 
Pharmaceutical Sciences. 2005; 64: 404–408. 
35. Guo J-H, Skinner GW, Harcum WW, et al. 
Pharmaceutical applications of naturally occurring 




April – June 2014 Volume XI                                                               Issue 2  17 
 
water-soluble polymers. Pharm Sci & Technol 
Today. 1998; 1: 254-61.  
36. Podual K, Doyle III FJ, Peppas NA. Dynamic 
behavior of glucose oxidase-containing 
microparticles of poly(ethylene)- grafted cationic 
hydrogels in an environment changing Ph. 
Biomaterials. 2000; 21: 1439-50. 
37. Nirmal HB, Bakliwal SR, Pawar SP. In-situ gel: 
New trends in Controlled and Sustained Drug 
Delivery System. International Journal of Pharm 
Tech Research. 2010; 2: 1398-1408. 
38. Dhirajkumar KC, Sushilkumar SP. Current Status 
of Ophthalmic In-situ Forming Hydrogel.  
International Journal of Pharma and Bio Sciences. 
2012; 3:  372-388. 
 
 
Received  24th May 2014 
Revised 2nd June 2014 
Accepted  9th June 2014 
J. App. Pharm. Res., 2 (2); 2014: 11 – 17   
